Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT149 | Individual Protein | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Homo sapiens | Potency | = | 31622.8 | nM | PubChem BioAssay data set |
NPT48 | Individual Protein | Lysine-specific demethylase 4D-like | Homo sapiens | Potency | = | 35481.3 | nM | PubChem BioAssay data set |
NPT442 | Individual Protein | Ferritin light chain | Equus caballus | Potency | = | 44668.4 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 10000 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | = | 17782.8 | nM | PubChem BioAssay data set | |
NPT55 | Individual Protein | Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | = | 7062.7 | nM | PubChem BioAssay data set |
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT151 | Individual Protein | 15-hydroxyprostaglandin dehydrogenase [NAD+] | Homo sapiens | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT1416 | Individual Protein | Neuropeptide S receptor | Homo sapiens | Potency | = | 10000 | nM | PubChem BioAssay data set |
NPT110 | Individual Protein | Cytochrome P450 2D6 | Homo sapiens | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | Potency | = | 15848.9 | nM | PubChem BioAssay data set |
NPT800 | Individual Protein | M-phase phosphoprotein 8 | Homo sapiens | Potency | 125.9 | nM | PubChem BioAssay data set | |
NPT5 | Individual Protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | 22.4 | nM | PubChem BioAssay data set | |
NPT5 | Individual Protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | 19952.6 | nM | PubChem BioAssay data set | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 9285 | nM | PubChem BioAssay data set | |
NPT1139 | Individual Protein | Arachidonate 15-lipoxygenase, type II | Homo sapiens | Potency | 12589.3 | nM | PubChem BioAssay data set | |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | 29081 | nM | PubChem BioAssay data set | |
NPT110 | Individual Protein | Cytochrome P450 2D6 | Homo sapiens | AC50 | = | 39810.72 | nM | PubChem BioAssay data set |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | AC50 | = | 15848.93 | nM | PubChem BioAssay data set |
NPT208 | Individual Protein | Cytochrome P450 1A2 | Homo sapiens | AC50 | = | 31622.78 | nM | PubChem BioAssay data set |
NPT7 | Individual Protein | Thioredoxin reductase 1, cytoplasmic | Rattus norvegicus | Potency | 4228.4 | nM | PubChem BioAssay data set | |
NPT803 | Individual Protein | Flap endonuclease 1 | Homo sapiens | Potency | 8436.8 | nM | PubChem BioAssay data set | |
NPT698 | Individual Protein | Regulator of G-protein signaling 4 | Homo sapiens | Potency | 18887.6 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 4107.8 | nM | PubChem BioAssay data set | ||
NPT7 | Individual Protein | Thioredoxin reductase 1, cytoplasmic | Rattus norvegicus | Potency | 31622.8 | nM | PubChem BioAssay data set | |
NPT699 | Individual Protein | UDP-glucuronosyltransferase 1-10 | Homo sapiens | Activity | = | 0 | pm/min/mg | 10836148 |
NPT903 | Individual Protein | UDP-glucuronosyltransferase 1-7 | Homo sapiens | Activity | = | 0 | pm/min/mg | 10836148 |
NPT697 | Individual Protein | UDP-glucuronosyltransferase 2B7 | Homo sapiens | Activity | = | 0 | pm/min/mg | 10836148 |
NPT1852 | Individual Protein | Rac GTPase-activating protein 1 | Homo sapiens | IC50 | 52260 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | IC50 | 50670 | nM | PubChem BioAssay data set | ||
NPT100 | Individual Protein | Glutaminase kidney isoform, mitochondrial | Homo sapiens | Potency | 12589.3 | nM | PubChem BioAssay data set | |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 112.2 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 4466.8 | nM | PubChem BioAssay data set | ||
NPT104 | Individual Protein | Cerebroside-sulfatase | Homo sapiens | Potency | 37933 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC316981 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9433 | High Similarity | NPC266931 |
0.9115 | High Similarity | NPC199277 |
0.9115 | High Similarity | NPC135887 |
0.9048 | High Similarity | NPC326634 |
0.8995 | High Similarity | NPC307963 |
0.8901 | High Similarity | NPC251090 |
0.8836 | High Similarity | NPC76748 |
0.8789 | High Similarity | NPC92111 |
0.8783 | High Similarity | NPC296527 |
0.873 | High Similarity | NPC46580 |
0.8624 | High Similarity | NPC314002 |
0.8579 | High Similarity | NPC171171 |
0.8571 | High Similarity | NPC204717 |
0.8549 | High Similarity | NPC99666 |
0.8519 | High Similarity | NPC220765 |
0.8515 | High Similarity | NPC11464 |
0.8513 | High Similarity | NPC13880 |
0.8419 | Intermediate Similarity | NPC295228 |
0.8392 | Intermediate Similarity | NPC232727 |
0.8365 | Intermediate Similarity | NPC193267 |
0.8365 | Intermediate Similarity | NPC213530 |
0.8358 | Intermediate Similarity | NPC285558 |
0.8342 | Intermediate Similarity | NPC176538 |
0.8333 | Intermediate Similarity | NPC280272 |
0.8307 | Intermediate Similarity | NPC96890 |
0.8307 | Intermediate Similarity | NPC184964 |
0.8281 | Intermediate Similarity | NPC84478 |
0.8276 | Intermediate Similarity | NPC193777 |
0.8265 | Intermediate Similarity | NPC217554 |
0.8252 | Intermediate Similarity | NPC112206 |
0.8252 | Intermediate Similarity | NPC202605 |
0.823 | Intermediate Similarity | NPC173080 |
0.8229 | Intermediate Similarity | NPC176127 |
0.8221 | Intermediate Similarity | NPC170114 |
0.8211 | Intermediate Similarity | NPC473183 |
0.8191 | Intermediate Similarity | NPC70956 |
0.8191 | Intermediate Similarity | NPC243834 |
0.8191 | Intermediate Similarity | NPC156704 |
0.8182 | Intermediate Similarity | NPC131017 |
0.8174 | Intermediate Similarity | NPC11408 |
0.8173 | Intermediate Similarity | NPC470549 |
0.8159 | Intermediate Similarity | NPC121772 |
0.8159 | Intermediate Similarity | NPC315957 |
0.8153 | Intermediate Similarity | NPC284141 |
0.8146 | Intermediate Similarity | NPC476465 |
0.8128 | Intermediate Similarity | NPC223427 |
0.8125 | Intermediate Similarity | NPC471080 |
0.8125 | Intermediate Similarity | NPC469592 |
0.8125 | Intermediate Similarity | NPC162530 |
0.8119 | Intermediate Similarity | NPC473184 |
0.8113 | Intermediate Similarity | NPC60621 |
0.81 | Intermediate Similarity | NPC77555 |
0.8073 | Intermediate Similarity | NPC72980 |
0.8069 | Intermediate Similarity | NPC234197 |
0.8068 | Intermediate Similarity | NPC167860 |
0.8068 | Intermediate Similarity | NPC123976 |
0.805 | Intermediate Similarity | NPC242209 |
0.804 | Intermediate Similarity | NPC106937 |
0.8029 | Intermediate Similarity | NPC208284 |
0.8029 | Intermediate Similarity | NPC246518 |
0.8028 | Intermediate Similarity | NPC310118 |
0.802 | Intermediate Similarity | NPC32771 |
0.801 | Intermediate Similarity | NPC88008 |
0.8009 | Intermediate Similarity | NPC110151 |
0.799 | Intermediate Similarity | NPC195268 |
0.799 | Intermediate Similarity | NPC48353 |
0.799 | Intermediate Similarity | NPC133140 |
0.798 | Intermediate Similarity | NPC315491 |
0.798 | Intermediate Similarity | NPC45459 |
0.798 | Intermediate Similarity | NPC213308 |
0.7972 | Intermediate Similarity | NPC469594 |
0.7971 | Intermediate Similarity | NPC475910 |
0.7962 | Intermediate Similarity | NPC8022 |
0.7962 | Intermediate Similarity | NPC470799 |
0.7951 | Intermediate Similarity | NPC162484 |
0.7931 | Intermediate Similarity | NPC476582 |
0.7931 | Intermediate Similarity | NPC476578 |
0.7931 | Intermediate Similarity | NPC4071 |
0.7913 | Intermediate Similarity | NPC475070 |
0.7913 | Intermediate Similarity | NPC16452 |
0.7913 | Intermediate Similarity | NPC476581 |
0.7913 | Intermediate Similarity | NPC36229 |
0.7909 | Intermediate Similarity | NPC473182 |
0.7907 | Intermediate Similarity | NPC118121 |
0.7902 | Intermediate Similarity | NPC475085 |
0.7902 | Intermediate Similarity | NPC475112 |
0.7902 | Intermediate Similarity | NPC291535 |
0.7895 | Intermediate Similarity | NPC5145 |
0.7892 | Intermediate Similarity | NPC329747 |
0.7887 | Intermediate Similarity | NPC204446 |
0.7885 | Intermediate Similarity | NPC18348 |
0.785 | Intermediate Similarity | NPC74360 |
0.7844 | Intermediate Similarity | NPC473185 |
0.7837 | Intermediate Similarity | NPC313189 |
0.7833 | Intermediate Similarity | NPC153042 |
0.782 | Intermediate Similarity | NPC53069 |
0.782 | Intermediate Similarity | NPC202768 |
0.782 | Intermediate Similarity | NPC296482 |
0.7805 | Intermediate Similarity | NPC329793 |
0.7805 | Intermediate Similarity | NPC19872 |
0.7805 | Intermediate Similarity | NPC477019 |
0.7804 | Intermediate Similarity | NPC473822 |
0.7793 | Intermediate Similarity | NPC277351 |
0.7783 | Intermediate Similarity | NPC478074 |
0.7778 | Intermediate Similarity | NPC476138 |
0.7778 | Intermediate Similarity | NPC245816 |
0.7767 | Intermediate Similarity | NPC31930 |
0.7762 | Intermediate Similarity | NPC185782 |
0.7762 | Intermediate Similarity | NPC469589 |
0.7751 | Intermediate Similarity | NPC183777 |
0.7736 | Intermediate Similarity | NPC26679 |
0.7725 | Intermediate Similarity | NPC131718 |
0.7718 | Intermediate Similarity | NPC249040 |
0.7717 | Intermediate Similarity | NPC214980 |
0.7707 | Intermediate Similarity | NPC72211 |
0.7706 | Intermediate Similarity | NPC122436 |
0.7704 | Intermediate Similarity | NPC88363 |
0.7703 | Intermediate Similarity | NPC476106 |
0.7696 | Intermediate Similarity | NPC222018 |
0.7692 | Intermediate Similarity | NPC475774 |
0.7688 | Intermediate Similarity | NPC94943 |
0.7685 | Intermediate Similarity | NPC473179 |
0.768 | Intermediate Similarity | NPC474409 |
0.7678 | Intermediate Similarity | NPC201697 |
0.7677 | Intermediate Similarity | NPC212535 |
0.7674 | Intermediate Similarity | NPC473513 |
0.7668 | Intermediate Similarity | NPC172222 |
0.7667 | Intermediate Similarity | NPC135549 |
0.7661 | Intermediate Similarity | NPC122463 |
0.7659 | Intermediate Similarity | NPC224928 |
0.7653 | Intermediate Similarity | NPC219087 |
0.7653 | Intermediate Similarity | NPC171409 |
0.7653 | Intermediate Similarity | NPC96405 |
0.765 | Intermediate Similarity | NPC174049 |
0.7647 | Intermediate Similarity | NPC252251 |
0.7644 | Intermediate Similarity | NPC102423 |
0.7639 | Intermediate Similarity | NPC303658 |
0.7639 | Intermediate Similarity | NPC264285 |
0.7638 | Intermediate Similarity | NPC190007 |
0.7635 | Intermediate Similarity | NPC324149 |
0.763 | Intermediate Similarity | NPC171787 |
0.7628 | Intermediate Similarity | NPC288349 |
0.7617 | Intermediate Similarity | NPC477610 |
0.761 | Intermediate Similarity | NPC70259 |
0.76 | Intermediate Similarity | NPC188387 |
0.76 | Intermediate Similarity | NPC163421 |
0.7594 | Intermediate Similarity | NPC174758 |
0.759 | Intermediate Similarity | NPC313791 |
0.7585 | Intermediate Similarity | NPC128823 |
0.7585 | Intermediate Similarity | NPC476167 |
0.7581 | Intermediate Similarity | NPC235076 |
0.7578 | Intermediate Similarity | NPC477531 |
0.7578 | Intermediate Similarity | NPC201508 |
0.7571 | Intermediate Similarity | NPC118832 |
0.7571 | Intermediate Similarity | NPC165349 |
0.7571 | Intermediate Similarity | NPC274291 |
0.7571 | Intermediate Similarity | NPC264166 |
0.7571 | Intermediate Similarity | NPC47059 |
0.7571 | Intermediate Similarity | NPC329708 |
0.757 | Intermediate Similarity | NPC251160 |
0.7562 | Intermediate Similarity | NPC204385 |
0.7561 | Intermediate Similarity | NPC276517 |
0.7561 | Intermediate Similarity | NPC43787 |
0.7561 | Intermediate Similarity | NPC205934 |
0.7559 | Intermediate Similarity | NPC188420 |
0.7559 | Intermediate Similarity | NPC471304 |
0.7558 | Intermediate Similarity | NPC23614 |
0.7558 | Intermediate Similarity | NPC100079 |
0.7557 | Intermediate Similarity | NPC153467 |
0.7551 | Intermediate Similarity | NPC312872 |
0.7547 | Intermediate Similarity | NPC82548 |
0.7536 | Intermediate Similarity | NPC192315 |
0.7536 | Intermediate Similarity | NPC306376 |
0.7536 | Intermediate Similarity | NPC472111 |
0.7535 | Intermediate Similarity | NPC271215 |
0.7535 | Intermediate Similarity | NPC149471 |
0.7534 | Intermediate Similarity | NPC477532 |
0.7534 | Intermediate Similarity | NPC209174 |
0.7523 | Intermediate Similarity | NPC87413 |
0.7522 | Intermediate Similarity | NPC78609 |
0.7512 | Intermediate Similarity | NPC476041 |
0.7512 | Intermediate Similarity | NPC304926 |
0.7512 | Intermediate Similarity | NPC209769 |
0.7512 | Intermediate Similarity | NPC325297 |
0.75 | Intermediate Similarity | NPC91868 |
0.75 | Intermediate Similarity | NPC63971 |
0.75 | Intermediate Similarity | NPC260434 |
0.7489 | Intermediate Similarity | NPC246381 |
0.7489 | Intermediate Similarity | NPC15801 |
0.7489 | Intermediate Similarity | NPC132642 |
0.7488 | Intermediate Similarity | NPC246700 |
0.7488 | Intermediate Similarity | NPC128084 |
0.7488 | Intermediate Similarity | NPC210256 |
0.7488 | Intermediate Similarity | NPC128751 |
0.7488 | Intermediate Similarity | NPC470500 |
0.7487 | Intermediate Similarity | NPC230869 |
0.7477 | Intermediate Similarity | NPC290689 |
0.7476 | Intermediate Similarity | NPC66815 |
0.7467 | Intermediate Similarity | NPC469554 |
0.7463 | Intermediate Similarity | NPC62069 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC316981 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8995 | High Similarity | NPD1038 | Approved |
0.8762 | High Similarity | NPD5612 | Discontinued |
0.8698 | High Similarity | NPD1304 | Clinical (unspecified phase) |
0.8693 | High Similarity | NPD5658 | Approved |
0.855 | High Similarity | NPD1392 | Approved |
0.8223 | Intermediate Similarity | NPD5575 | Clinical (unspecified phase) |
0.8213 | Intermediate Similarity | NPD1322 | Clinical (unspecified phase) |
0.82 | Intermediate Similarity | NPD1768 | Approved |
0.8177 | Intermediate Similarity | NPD4795 | Phase 2 |
0.8173 | Intermediate Similarity | NPD5903 | Approved |
0.8173 | Intermediate Similarity | NPD5902 | Approved |
0.8159 | Intermediate Similarity | NPD1740 | Approved |
0.8159 | Intermediate Similarity | NPD1739 | Approved |
0.8157 | Intermediate Similarity | NPD6494 | Phase 2 |
0.8157 | Intermediate Similarity | NPD7558 | Phase 2 |
0.8146 | Intermediate Similarity | NPD2189 | Approved |
0.8146 | Intermediate Similarity | NPD2187 | Approved |
0.8137 | Intermediate Similarity | NPD3003 | Approved |
0.804 | Intermediate Similarity | NPD802 | Phase 2 |
0.8018 | Intermediate Similarity | NPD8512 | Phase 3 |
0.799 | Intermediate Similarity | NPD3921 | Approved |
0.799 | Intermediate Similarity | NPD3924 | Approved |
0.799 | Intermediate Similarity | NPD3922 | Approved |
0.799 | Intermediate Similarity | NPD3923 | Approved |
0.798 | Intermediate Similarity | NPD484 | Approved |
0.7943 | Intermediate Similarity | NPD5067 | Phase 2 |
0.7943 | Intermediate Similarity | NPD5066 | Phase 2 |
0.7931 | Intermediate Similarity | NPD3825 | Phase 3 |
0.7921 | Intermediate Similarity | NPD7948 | Phase 1 |
0.7907 | Intermediate Similarity | NPD1954 | Phase 1 |
0.7843 | Intermediate Similarity | NPD4118 | Clinical (unspecified phase) |
0.7822 | Intermediate Similarity | NPD3324 | Clinical (unspecified phase) |
0.782 | Intermediate Similarity | NPD3816 | Phase 1 |
0.782 | Intermediate Similarity | NPD3815 | Phase 1 |
0.7814 | Intermediate Similarity | NPD6242 | Discontinued |
0.7751 | Intermediate Similarity | NPD7453 | Approved |
0.7751 | Intermediate Similarity | NPD7452 | Approved |
0.7751 | Intermediate Similarity | NPD7222 | Phase 2 |
0.7713 | Intermediate Similarity | NPD6964 | Approved |
0.7713 | Intermediate Similarity | NPD6963 | Approved |
0.7688 | Intermediate Similarity | NPD6344 | Clinical (unspecified phase) |
0.7665 | Intermediate Similarity | NPD4875 | Phase 3 |
0.7665 | Intermediate Similarity | NPD4876 | Phase 3 |
0.765 | Intermediate Similarity | NPD5930 | Phase 3 |
0.7611 | Intermediate Similarity | NPD7729 | Clinical (unspecified phase) |
0.7598 | Intermediate Similarity | NPD6230 | Discontinued |
0.7574 | Intermediate Similarity | NPD8091 | Phase 3 |
0.7571 | Intermediate Similarity | NPD4038 | Approved |
0.7571 | Intermediate Similarity | NPD4036 | Approved |
0.7571 | Intermediate Similarity | NPD4037 | Approved |
0.7571 | Intermediate Similarity | NPD4039 | Approved |
0.7571 | Intermediate Similarity | NPD4033 | Approved |
0.7571 | Intermediate Similarity | NPD31 | Approved |
0.7571 | Intermediate Similarity | NPD4034 | Approved |
0.7571 | Intermediate Similarity | NPD32 | Approved |
0.7571 | Intermediate Similarity | NPD4035 | Approved |
0.7571 | Intermediate Similarity | NPD4122 | Approved |
0.7569 | Intermediate Similarity | NPD5070 | Clinical (unspecified phase) |
0.7561 | Intermediate Similarity | NPD4418 | Discontinued |
0.7546 | Intermediate Similarity | NPD6803 | Clinical (unspecified phase) |
0.7543 | Intermediate Similarity | NPD6244 | Phase 3 |
0.7543 | Intermediate Similarity | NPD6243 | Phase 3 |
0.7525 | Intermediate Similarity | NPD3920 | Phase 2 |
0.7523 | Intermediate Similarity | NPD4131 | Phase 3 |
0.7521 | Intermediate Similarity | NPD4926 | Clinical (unspecified phase) |
0.7512 | Intermediate Similarity | NPD7823 | Clinical (unspecified phase) |
0.7489 | Intermediate Similarity | NPD5559 | Phase 2 |
0.7479 | Intermediate Similarity | NPD7859 | Phase 2 |
0.7477 | Intermediate Similarity | NPD6985 | Discontinued |
0.7443 | Intermediate Similarity | NPD7194 | Discontinued |
0.7443 | Intermediate Similarity | NPD3763 | Approved |
0.7442 | Intermediate Similarity | NPD949 | Phase 1 |
0.7438 | Intermediate Similarity | NPD6257 | Clinical (unspecified phase) |
0.7436 | Intermediate Similarity | NPD6872 | Clinical (unspecified phase) |
0.7436 | Intermediate Similarity | NPD6503 | Clinical (unspecified phase) |
0.7434 | Intermediate Similarity | NPD4080 | Discontinued |
0.7424 | Intermediate Similarity | NPD7025 | Clinical (unspecified phase) |
0.7424 | Intermediate Similarity | NPD5905 | Phase 1 |
0.7404 | Intermediate Similarity | NPD2952 | Discontinued |
0.7397 | Intermediate Similarity | NPD3354 | Phase 2 |
0.7389 | Intermediate Similarity | NPD4885 | Approved |
0.7385 | Intermediate Similarity | NPD8510 | Clinical (unspecified phase) |
0.7374 | Intermediate Similarity | NPD1923 | Clinical (unspecified phase) |
0.7368 | Intermediate Similarity | NPD4454 | Phase 2 |
0.7363 | Intermediate Similarity | NPD7414 | Clinical (unspecified phase) |
0.7361 | Intermediate Similarity | NPD4502 | Phase 2 |
0.736 | Intermediate Similarity | NPD4083 | Discontinued |
0.7345 | Intermediate Similarity | NPD4995 | Approved |
0.7345 | Intermediate Similarity | NPD4996 | Approved |
0.7318 | Intermediate Similarity | NPD8405 | Clinical (unspecified phase) |
0.7318 | Intermediate Similarity | NPD5632 | Approved |
0.7301 | Intermediate Similarity | NPD1900 | Clinical (unspecified phase) |
0.7301 | Intermediate Similarity | NPD4925 | Approved |
0.7295 | Intermediate Similarity | NPD6569 | Phase 2 |
0.7286 | Intermediate Similarity | NPD5065 | Approved |
0.7277 | Intermediate Similarity | NPD4203 | Approved |
0.7277 | Intermediate Similarity | NPD4204 | Approved |
0.7273 | Intermediate Similarity | NPD2921 | Clinical (unspecified phase) |
0.7264 | Intermediate Similarity | NPD4511 | Phase 1 |
0.726 | Intermediate Similarity | NPD4551 | Phase 2 |
0.7243 | Intermediate Similarity | NPD3397 | Phase 2 |
0.7238 | Intermediate Similarity | NPD1622 | Discontinued |
0.7233 | Intermediate Similarity | NPD4021 | Phase 2 |
0.7222 | Intermediate Similarity | NPD4184 | Clinical (unspecified phase) |
0.7222 | Intermediate Similarity | NPD1325 | Approved |
0.7222 | Intermediate Similarity | NPD1326 | Approved |
0.7222 | Intermediate Similarity | NPD5483 | Clinical (unspecified phase) |
0.721 | Intermediate Similarity | NPD6517 | Phase 3 |
0.7186 | Intermediate Similarity | NPD1078 | Clinical (unspecified phase) |
0.7179 | Intermediate Similarity | NPD7067 | Approved |
0.7179 | Intermediate Similarity | NPD7068 | Approved |
0.7178 | Intermediate Similarity | NPD1620 | Clinical (unspecified phase) |
0.717 | Intermediate Similarity | NPD2177 | Approved |
0.717 | Intermediate Similarity | NPD2176 | Approved |
0.717 | Intermediate Similarity | NPD2175 | Phase 3 |
0.7169 | Intermediate Similarity | NPD3330 | Phase 1 |
0.7149 | Intermediate Similarity | NPD4349 | Approved |
0.7149 | Intermediate Similarity | NPD4350 | Approved |
0.7143 | Intermediate Similarity | NPD3395 | Approved |
0.7143 | Intermediate Similarity | NPD3396 | Approved |
0.7137 | Intermediate Similarity | NPD5051 | Phase 1 |
0.7137 | Intermediate Similarity | NPD5833 | Phase 1 |
0.713 | Intermediate Similarity | NPD8403 | Phase 1 |
0.7129 | Intermediate Similarity | NPD4072 | Approved |
0.7129 | Intermediate Similarity | NPD5751 | Clinical (unspecified phase) |
0.7129 | Intermediate Similarity | NPD4071 | Approved |
0.7123 | Intermediate Similarity | NPD3570 | Phase 2 |
0.711 | Intermediate Similarity | NPD4437 | Phase 3 |
0.7105 | Intermediate Similarity | NPD7555 | Discontinued |
0.7097 | Intermediate Similarity | NPD3930 | Clinical (unspecified phase) |
0.7093 | Intermediate Similarity | NPD7603 | Discontinued |
0.7091 | Intermediate Similarity | NPD7069 | Discontinued |
0.7089 | Intermediate Similarity | NPD3814 | Phase 1 |
0.7074 | Intermediate Similarity | NPD7589 | Clinical (unspecified phase) |
0.7073 | Intermediate Similarity | NPD6773 | Clinical (unspecified phase) |
0.7072 | Intermediate Similarity | NPD6147 | Clinical (unspecified phase) |
0.7064 | Intermediate Similarity | NPD5863 | Clinical (unspecified phase) |
0.7064 | Intermediate Similarity | NPD6473 | Phase 1 |
0.7062 | Intermediate Similarity | NPD1602 | Discontinued |
0.7062 | Intermediate Similarity | NPD6861 | Clinical (unspecified phase) |
0.7061 | Intermediate Similarity | NPD6553 | Clinical (unspecified phase) |
0.7059 | Intermediate Similarity | NPD3886 | Phase 1 |
0.7059 | Intermediate Similarity | NPD6595 | Phase 3 |
0.7056 | Intermediate Similarity | NPD6219 | Discontinued |
0.7054 | Intermediate Similarity | NPD3402 | Phase 1 |
0.7054 | Intermediate Similarity | NPD8442 | Discontinued |
0.7053 | Intermediate Similarity | NPD5256 | Discontinued |
0.7051 | Intermediate Similarity | NPD3932 | Clinical (unspecified phase) |
0.7051 | Intermediate Similarity | NPD4862 | Clinical (unspecified phase) |
0.7051 | Intermediate Similarity | NPD5530 | Phase 1 |
0.7048 | Intermediate Similarity | NPD7719 | Discontinued |
0.704 | Intermediate Similarity | NPD5164 | Discontinued |
0.7037 | Intermediate Similarity | NPD7955 | Approved |
0.7037 | Intermediate Similarity | NPD7956 | Approved |
0.7034 | Intermediate Similarity | NPD7620 | Phase 2 |
0.7033 | Intermediate Similarity | NPD3343 | Phase 3 |
0.7033 | Intermediate Similarity | NPD8284 | Discontinued |
0.7032 | Intermediate Similarity | NPD1297 | Clinical (unspecified phase) |
0.7032 | Intermediate Similarity | NPD2125 | Clinical (unspecified phase) |
0.7029 | Intermediate Similarity | NPD5482 | Discontinued |
0.7027 | Intermediate Similarity | NPD6140 | Clinical (unspecified phase) |
0.7018 | Intermediate Similarity | NPD7676 | Clinical (unspecified phase) |
0.7018 | Intermediate Similarity | NPD7675 | Phase 3 |
0.7018 | Intermediate Similarity | NPD7674 | Phase 3 |
0.7018 | Intermediate Similarity | NPD7426 | Phase 1 |
0.7012 | Intermediate Similarity | NPD5539 | Phase 2 |
0.7009 | Intermediate Similarity | NPD4548 | Discontinued |
0.7009 | Intermediate Similarity | NPD5999 | Phase 2 |
0.7008 | Intermediate Similarity | NPD6531 | Approved |
0.7008 | Intermediate Similarity | NPD6530 | Approved |
0.7005 | Intermediate Similarity | NPD4889 | Approved |
0.7 | Intermediate Similarity | NPD5641 | Discontinued |
0.7 | Intermediate Similarity | NPD7567 | Approved |
0.6996 | Remote Similarity | NPD7112 | Discontinued |
0.6995 | Remote Similarity | NPD749 | Clinical (unspecified phase) |
0.6991 | Remote Similarity | NPD5669 | Clinical (unspecified phase) |
0.6987 | Remote Similarity | NPD4558 | Phase 2 |
0.6987 | Remote Similarity | NPD5007 | Approved |
0.6983 | Remote Similarity | NPD5040 | Clinical (unspecified phase) |
0.6982 | Remote Similarity | NPD5945 | Phase 1 |
0.6982 | Remote Similarity | NPD5944 | Phase 1 |
0.6977 | Remote Similarity | NPD4396 | Clinical (unspecified phase) |
0.6968 | Remote Similarity | NPD7470 | Discontinued |
0.6968 | Remote Similarity | NPD1300 | Discontinued |
0.6967 | Remote Similarity | NPD3634 | Approved |
0.6967 | Remote Similarity | NPD3633 | Approved |
0.6966 | Remote Similarity | NPD4343 | Phase 1 |
0.6966 | Remote Similarity | NPD4344 | Clinical (unspecified phase) |
0.6964 | Remote Similarity | NPD7980 | Clinical (unspecified phase) |
0.6962 | Remote Similarity | NPD7413 | Phase 3 |
0.6957 | Remote Similarity | NPD5083 | Clinical (unspecified phase) |
0.6953 | Remote Similarity | NPD2757 | Phase 2 |
0.6952 | Remote Similarity | NPD2843 | Phase 2 |
0.6952 | Remote Similarity | NPD2845 | Phase 2 |
0.6951 | Remote Similarity | NPD4897 | Phase 2 |
0.6948 | Remote Similarity | NPD3255 | Phase 1 |
0.6948 | Remote Similarity | NPD3254 | Phase 1 |
0.6946 | Remote Similarity | NPD482 | Approved |
0.6942 | Remote Similarity | NPD3386 | Phase 2 |
0.6939 | Remote Similarity | NPD6228 | Discontinued |
PubChem CID   | 1864 |
ChEMBL   | CHEMBL127421 |
ZINC   |
Molecular Weight:   | 248.12 |
ALogP:   | -0.9612 |
MLogP:   | 2.34 |
XLogP:   | 0.797 |
# Rotatable Bonds:   | 8 |
Polar Surface Area:   | 77.84 |
# H-Bond Aceptor:   | 3 |
# H-Bond Donor:   | 3 |
# Rings:   | 2 |
# Heavy Atoms:   | 18 |